by AKU | Apr 10, 2024 | AKU Blog
We are excited to announce the launch of our global AKU patient registry. Our registry will play a crucial role in increasing our understanding of AKU and driving research into potential treatments and cures. Over the past year, we have been working with...
by AKU | Feb 15, 2024 | AKU Blog
Our latest blog is written by Liesbeth Desmet, a PhD student at the Vrije Universiteit Brussel (VUB). She recently participated in our early-stage researcher bursary programme to visit the University of Liverpool and expand her knowledge of AKU research: I am a PhD...
by AKU | Feb 9, 2024 | AKU Blog, Uncategorized
Our latest blog looks at CyclePharma and Inceptua Group’s Free Goods Programme which will support AKU patients in 16 countries around the world to access nitisinone. Nitisinone is a vital treatment for AKU, but it is not yet approved or commercially available in many...
by AKU | Jul 9, 2023 | AKU Blog, Uncategorized
On the 27-28th July we hosted our 13th International Scientific Conference on AKU in Bratislava, Slovakia, which had a focus on treating hypertyrosinaemia in AKU and HT-1. This latest conference was our largest to date, with over 100 attendees from 19 countries...
by AKU | Jun 13, 2023 | AKU Blog
We are looking forward to welcoming the AKU scientific community to Bratislava, Slovakia, next month for our 13th international scientific conference on AKU. On the 27-28th of July we will unite AKU researchers, academics, and clinicians from around the world at...
by AKU | Apr 5, 2023 | AKU Blog
We are pleased to announce that we are hosting our 13th international conference on AKU, which will be held from the 27-28th of July. It will be held at the Faculty of Medicine, Comenius University, in Bratislava, Slovakia. The focus of the conference will be on...
